Sign In
Buy SNY
$42.37
-0.430 (-1.00%)
At Close: Jun 03, 2026
Does PFE, ARNA Deal Signal Robust Pharma M&A Activity in 2022?
10:44am, Tuesday, 14'th Dec 2021
The Pfizer (PFE)-Arena (ARNA) deal raises hopes that M&A activity will pick up significantly in 2022. as big drugmakers are sitting on huge piles of cash.
Women''S Health Market is a completely ready-to-refer market research presentation that offers vital information, such as market share, market size, CAGR, and the directly impacting factors. The updated research report presents actionable insights to the market vendors involved and other
New Jersey, United States,- Verified Market Research has recently published a research report titled, “Dementia Drugs Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application”. Primary and secondary research methodologies have been used to formulate
The Hydroxychloroquine Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate
Covid-19 Impact on Asthma Treatment Drugs Market is Likely to Experience a Tremendous Growth by 2027 | GlaxoSmithKline, Sanofi
04:52pm, Monday, 13'th Dec 2021 OpenPR
Another exploration Titled "Worldwide Asthma Treatment Drugs 2019-Market Research Report" gives the Professional and inside and out assessment of extent of momentum and future market and survey of Product Specification, showcase pattern , item type and creation investigation considering central
Sanofi (SNY) Multiple Myeloma Phase III Study Meets Goal
01:50pm, Monday, 13'th Dec 2021
Sanofi's (SNY) phase III study on Sarclisa is the first to meet the primary endpoint of MRD negativity in transplant-eligible patients with newly diagnosed multiple myeloma.
DUBLIN--(BUSINESS WIRE)--The "Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. The global multiple sclerosis drugs market is expected to grow from $21.27 billion in 2020 to $22.04 billion in 2021 at a compound annual growth rate (CAGR) of 3.6%. The market is expected to reach $25.95 billion in 2025 at a CAGR of 4%. Major players in the multiple sclerosis drugs market are Biogen, Novartis, Roche, B
Animal Vaccines Market: Future Forecast Assessed on the Basis of How the Key Players Decided to Invest: Merck, Zoetis, Ceva Sant Animale, Sanofi
01:41pm, Monday, 13'th Dec 2021 OpenPR
The latest release from WMR titled Animal Vaccines Market Research Report 2021-2027 (by Product Type, End-User / Application, and Regions / Countries) provides an in-depth assessment of the Animal Vaccines including key market trends, upcoming technologies, industry drivers, challenges, regulatory
Hydroxychloroquine Market Growth in Future Scope 2021-2028 | Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited
01:17pm, Monday, 13'th Dec 2021 OpenPR
The Hydroxychloroquine Market report focus on the current trends of the market along with detailed analysis which provides data regarding this market rate, and it also predicts the future market growth rate. The Hydroxychloroquine Market study includes research on the
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
12:12pm, Monday, 13'th Dec 2021
Sanofi SA (NASDAQ: SNY) and Johnson & Johnson (NYSE: JNJ) posted new data from their myeloma therapies, Sarclisa and Darzalex, respectively. Data were shared at the American Society of Hematology (
New Jersey, United States,- Verified Market Research has recently published a research report titled, Phosphate Binders Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. Primary and secondary research methodologies have been used to formulate
Antifungal Agents Market To Witness Huge Growth By 2027 with Top Key Players Gilead, Enzon, Kramer, Merck, Sanofi, Novartis
09:10am, Monday, 13'th Dec 2021 OpenPR
The global Antifungal Agents market was valued at 1116.22 Million USD in 2020 and will grow with a CAGR of 2.71% from 2020 to 2027. The report covers the key players of the industry including Company Profile, Product Specifications, Production
New Jersey, United States,- Verified Market Research has recently published a research report titled, “Plastic Surgery And Integumentary System Procedures Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application”. Primary and secondary research methodologies have
Sanofi - Aventis Groupe: Positive Phase 3 Dupixent (dupilumab) data in children 6 months to 5 years with moderate-to-severe atopic dermatitis featured in RAD 2021 late-breaking session
06:05am, Monday, 13'th Dec 2021 FinanzNachrichten
Positive Phase 3 Dupixent (dupilumab) data in children 6 months to 5 years with moderate-to-severe atopic dermatitis featured in RAD 2021 late-breaking session Dupixent significantly improved skin
Sangamo Therapeutics Announces Updated Preliminary SAR445136 Phase 1/2 Proof-of-Concept Data Showing Tolerability and Sustained Effects in Sickle Cell Disease
02:00pm, Sunday, 12'th Dec 2021 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced updated preliminary proof-of-concept clinical data from the Phase 1/2 PRECIZN-1 study of SAR445136, a zinc finger nuclease gene-edited cell therapy candidate in development with Sanofi for the treatment of sickle cell disease (SCD). These data are being presented today at the 63rd American Society for Hematology Annual Meeting and Exposition taking place from December 11-14
